Thermo Fisher Scientific Inc. (TMO) Free Cash Flow
Thermo Fisher Scientific Inc. (TMO) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $2.84B |
| 2017-12-31 | $3.51B |
| 2018-12-31 | $6.77B |
| 2019-12-31 | $4.08B |
| 2020-12-31 | $6.82B |
| 2021-12-31 | $6.79B |
| 2022-12-31 | $6.91B |
| 2023-12-31 | $6.93B |
| 2024-12-31 | $7.27B |
| 2025-12-31 | $6.29B |
How TMO compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ABT | Abbott Laboratories | $7.39B |
| DHR | Danaher Corporation | $5.26B |
| REGN | Regeneron Pharmaceuticals Inc. | $4.08B |
| BSX | Boston Scientific Corporation | $3.66B |
| VRTX | Vertex Pharmaceuticals Incorporated | $3.19B |
These are five companies in the same sector as TMO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Thermo Fisher Scientific Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("TMO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMO | $622.18 | -1.35% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 |